Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Minority Interest (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Minority Interest for 6 consecutive years, with -$328649.0 as the latest value for Q3 2025.

  • On a quarterly basis, Minority Interest changed 0.05% to -$328649.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$328649.0, a 0.05% change, with the full-year FY2024 number at -$328483.0, changed 0.02% from a year prior.
  • Minority Interest was -$328649.0 for Q3 2025 at Ensysce Biosciences, roughly flat from -$328649.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of -$243653.0 in Q2 2021 to a low of -$328649.0 in Q2 2025.
  • A 5-year average of -$312900.6 and a median of -$327439.0 in 2022 define the central range for Minority Interest.
  • Peak YoY movement for Minority Interest: crashed 566.96% in 2021, then changed 0.0% in 2025.
  • Ensysce Biosciences' Minority Interest stood at -$279815.0 in 2021, then decreased by 12.65% to -$315208.0 in 2022, then dropped by 4.19% to -$328409.0 in 2023, then decreased by 0.02% to -$328483.0 in 2024, then fell by 0.05% to -$328649.0 in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Minority Interest are -$328649.0 (Q3 2025), -$328649.0 (Q2 2025), and -$328483.0 (Q1 2025).